PF-Atlas › Clinical Trials › NCT06967805

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis

MTX-463 · Phase 2

Registry ID

NCT06967805

Phase

Phase 2

Status

Recruiting

Drug / intervention

MTX-463

Sponsor

Mediar Therapeutics

Start

2025-05-05

Enrollment

164

Locations

About this trial

A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-463 in Participants with Idiopathic Pulmonary Fibrosis (IPF)

View NCT06967805 on ClinicalTrials.gov →

Explore related

All MTX-463 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT06967805 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.